Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Jost

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1997
Index of pretreatment intensity predicts outcome of high-dose chemotherapy and autologous progenitor cell transplantation in chemosensitive relapse of Hodgkin's diseaseL M Jost, L Widmer, H P Honegger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 13, 2005
ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancerB C Pestalozzi, E Luporsi-Gely, L M Jost, et al.
Schweizerische Medizinische Wochenschrift|February 4, 1988
[Immunotherapy of tumors using interleukin-2 and lymphokine-activated killer cells]L M Jost, J Gmür, O Oelz, et al.
British Journal of Cancer|July 1, 1990
Thyroiditis after treatment with interleukin-2 and interferon alpha-2aG Pichert, L M Jost, L Zöbeli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Randomized trial showing equivalent efficacy of filgrastim 5 micrograms/kg/d and 10 micrograms/kg/d following high-dose chemotherapy and autologous bone marrow transplantation in high-risk lymphomasR A Stahel, L M Jost, H Honegger, et al.
Journal of Children'S Orthopaedics|May 23, 2017
The modified Dunn procedure for slipped capital femoral epiphysis: the Bernese experienceM Tannast, L M Jost, T D Lerch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998
Selection and immunomagnetic purging of peripheral blood CD34+ cells for autologous transplantation in B-cell non-Hodgkin's lymphomasG Pichert, D Schmitter, L Widmer, et al.
Schweizerische Medizinische Wochenschrift|June 24, 1989
[High-dosage chemo-radiotherapy with autologous bone marrow transfusion in malignant lymphoma: indications and personal experience]R A Stahel, L M Jost, J Burger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1995
Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patientsL M Jost, E Jacky, C Dommann-Scherrer, et al.
Schweizerische Medizinische Wochenschrift|May 8, 1993
[5 years of dosage intensification and autologous bone marrow or peripheral stem cell transfusion in malignant lymphoma with a high risk of recurrence]L M Jost, G Pichert, M Reichlin, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1997
Index of pretreatment intensity predicts outcome of high-dose chemotherapy and autologous progenitor cell transplantation in chemosensitive relapse of Hodgkin's diseaseL M Jost, L Widmer, H P Honegger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 13, 2005
ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancerB C Pestalozzi, E Luporsi-Gely, L M Jost, et al.
Schweizerische Medizinische Wochenschrift|February 4, 1988
[Immunotherapy of tumors using interleukin-2 and lymphokine-activated killer cells]L M Jost, J Gmür, O Oelz, et al.
British Journal of Cancer|July 1, 1990
Thyroiditis after treatment with interleukin-2 and interferon alpha-2aG Pichert, L M Jost, L Zöbeli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Randomized trial showing equivalent efficacy of filgrastim 5 micrograms/kg/d and 10 micrograms/kg/d following high-dose chemotherapy and autologous bone marrow transplantation in high-risk lymphomasR A Stahel, L M Jost, H Honegger, et al.
Journal of Children'S Orthopaedics|May 23, 2017
The modified Dunn procedure for slipped capital femoral epiphysis: the Bernese experienceM Tannast, L M Jost, T D Lerch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998
Selection and immunomagnetic purging of peripheral blood CD34+ cells for autologous transplantation in B-cell non-Hodgkin's lymphomasG Pichert, D Schmitter, L Widmer, et al.
Schweizerische Medizinische Wochenschrift|June 24, 1989
[High-dosage chemo-radiotherapy with autologous bone marrow transfusion in malignant lymphoma: indications and personal experience]R A Stahel, L M Jost, J Burger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1995
Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patientsL M Jost, E Jacky, C Dommann-Scherrer, et al.
Schweizerische Medizinische Wochenschrift|May 8, 1993
[5 years of dosage intensification and autologous bone marrow or peripheral stem cell transfusion in malignant lymphoma with a high risk of recurrence]L M Jost, G Pichert, M Reichlin, et al.
Pageof 4